Title of article
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals
Author/Authors
Heart Protection Study Collaborative Group، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2005
Pages
7
From page
1779
To page
1785
Abstract
Background
Statin therapy reduces the rates of heart attack, stroke, and revascularisation among a wide range of individuals. Reliable assessment of its cost-effectiveness in different circumstances is needed.
Methods
20 536 adults (aged 40–80 years) wit
Journal title
The Lancet
Serial Year
2005
Journal title
The Lancet
Record number
588115
Link To Document